Promacta
Thanks Birgitta, that is encouraging news. Apparently NIH has not started clinical trials of Promacta in low risk patients, only in AA and high risk MDS. At least it gives us low platelet patients some continued hope. Tytd
__________________
possible low to int-1 MDS with predominant thrombocytopenia, mild anemia, dx 7/08, in watch and wait mode
|